REPLIMUNE GROUP, INC. Shares of Common Stock ($0.001 par value per share) SALES AGREEMENTSales Agreement • August 3rd, 2023 • Replimune Group, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 3rd, 2023 Company Industry JurisdictionReplimune Group, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows: